(Q44094176)

29 November 2017

Treatment with an adenosine uptake inhibitor attenuates glomerulonephritis in mice (English)

1 reference

29 November 2017

1 reference

Tohru Noji

1

1 reference

29 November 2017

Hitoshi Sato

2

1 reference

29 November 2017

Jun-ichi Sano

3

1 reference

29 November 2017

Satoshi Nishikawa

4

1 reference

29 November 2017

Hideaki Kusaka

5

1 reference

29 November 2017

Akira Karasawa

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

European Journal of Pharmacology

29 November 2017

1 reference

29 November 2017

449

1 reference

29 November 2017

3

1 reference

29 November 2017

293-300

1 reference

Adenosine receptor subtypes

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Endogenous adenosine curtails lipopolysaccharide-stimulated tumour necrosis factor synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

A DNA element in the alpha1 type III collagen promoter mediates a stimulatory response by angiotensin II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Adenosine induced fall in glomerular capillary pressure. Effect of ureteral obstruction and aortic constriction in the Munich-Wistar rat kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

5'-Nucleotidase as a marker of both general and local inflammation in rheumatoid arthritis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Inhibition of human monocyte TNF production by adenosine receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Turnover of adenosine in plasma of human and dog blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Experimental glomerulonephritis in mice as a model for immunopharmacological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

KF24345, an adenosine uptake inhibitor, suppresses lipopolysaccharide-induced tumor necrosis factor-alpha production and leukopenia via endogenous adenosine in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Adenosine receptor subtypes: characterization and therapeutic regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Renal action of adenosine: effect on renin secretion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Adenosine as a possible mediator of metabolic control of glomerular filtration rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Optimization of culture conditions for the preservation of monkey pancreatic islets in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2902039-3

10.1016/S0014-2999(02)02039-3

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference